Logo





  About us
  Advertising
  Privacy
  Terms
  Directory
  Submit Feed
  Analytics
  Trending
  Bias
  Trust Ranking
  API

Financial Times // Business // Finance

AbbVie shares tumble after schizophrenia drug disappoints

Monday 11th November 2024, 6:49PM

US pharma group says patients who took Emraclidine in clinical trials failed to show a significant decline in symptoms

Full Story